GRAFALON, Infusionslösungskonzentrat

7680524120014 CH-52412 Infusionslösungskonzentrat
GRAFALON, Infusionslösungskonzentrat
GRAFALON, Infusionslösungskonzentrat
GRAFALON, Infusionslösungskonzentrat
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionslösungskonzentrat
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/08/2025
Summary of Product Characteristics
Français
06/08/2025
Summary of Product Characteristics
Italien
06/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 421.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

Neovii Pharmaceuticals AG

None Rapperswil-Jona

Authorization information

Swissmedic authorization number
52412
Drug name
GRAFALON, Infusionslösungskonzentrat
Galenic form
LSPA
ATC Code
L04AA04
Authorization status
Z
Dispensing category
B
First authorization
16/06/1994
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Prophylaxe und Therapie von Abstossungskrisen nach Transplantationen

Package details

Description (FR)
GRAFALON conc perf 100 mg/5ml flac 5 ml
Description (DE)
GRAFALON Inf Konz 100 mg/5ml Durchstf 5 ml
Market launch
23/05/1996
Narcotic (BTM)
No

Application methods

IV

Other package sizes (5)

GRAFALON conc perf 100 mg/5ml 10 flac 5 ml
10 DUR
GTIN: 7680524120021
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1